176 filings
Page 5 of 9
8-K
2c5m 3u5rq1
17 Nov 20
Three months post-gene therapy, first patient in Gaucher trial shows reductions in the toxic metabolite
7:39am
8-K
f8bws
5 Nov 20
AVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update
7:18am
8-K
0f3b3m7
21 Oct 20
AVROBIO Appoints Dr. Gail Farfel to its Board of Directors
8:19am
8-K
61p la5hbjywh9ai
6 Oct 20
Regulation FD Disclosure
8:29am
8-K
wgrgm5wx
5 Oct 20
AVROBIO Expands Lentiviral Gene Therapy Pipeline with Program for Hunter Syndrome
7:10am
S-8
rtmejc4cw14an
6 Aug 20
Registration of securities for employees
7:28am
8-K
r2yq4xckpr 1es
6 Aug 20
AVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update
7:07am
8-K
okqpbs14 hybg2bo
6 Jul 20
AVROBIO Announces New Patients Dosed in Gaucher Disease and Cystinosis Clinical Trials
7:35am
8-K
slw g9k1xvhbmi
16 Jun 20
Regulation FD Disclosure
8:24am
8-K
m89lull
9 Jun 20
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
2ke6jkxl
14 May 20
Regulation FD Disclosure
7:05am
8-K
qxm ovqcmogjtnvejn
13 May 20
Regulation FD Disclosure
7:06am
8-K
pi1q90fckq1q2wv8dqwg
7 May 20
AVROBIO Reports 1Q 2020 Financial Results and Provides Business Update
7:06am
DEFA14A
r4h9h5v fp6iilo
22 Apr 20
Additional proxy soliciting materials
4:36pm
8-K
swdkx21
3 Apr 20
Regulation FD Disclosure
8:01am
8-K
86bqwmebo okp8avjc
30 Mar 20
Other Events
4:50pm